Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer

Purpose: Despite high initial response rates with cytoreductive surgery, conventional chemotherapy and the incorporation of biologic agents, ovarian cancer patients often relapse and die from their disease. New approaches are needed to improve patient outcomes. This study was designed to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeligs, Kristen P., Morelli, Maria Pia, David, Justin M., Neuman, Monica, Hernandez, Lidia, Hewitt, Stephen, Ozaki, Michelle, Osei-Tutu, Akosua, Anderson, David, Andresson, Thorkell, Das, Sudipto, Lack, Justin, Abdelmaksoud, Abdalla, Fantini, Massimo, Arlen, Philip M., Tsang, Kwong Y., Annunziata, Christina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318110/
https://www.ncbi.nlm.nih.gov/pubmed/32637350
http://dx.doi.org/10.3389/fonc.2020.00805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318110/
https://www.ncbi.nlm.nih.gov/pubmed/32637350
http://dx.doi.org/10.3389/fonc.2020.00805

Ejemplares similares